MOTS-c - 10mg

MOTS-c — Mitochondrial power for metabolism, performance & healthy aging. Unleash cleaner energy, steadier glucose control, and next-level stamina. MOTS-c is a mitochondria-encoded peptide that switches on AMPK, optimizes fuel use, supports insulin sensitivity, and helps you push harder and recover faster—while also dialing down inflammation and cellular stress responses linked to aging.

Peptide Profile

• Peptide Name: MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c)
• CAS Number: 1627580-64-6
• Molecular Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂ (free peptide)
• Primary Function: Metabolic regulator; AMPK activation; exercise-mimetic effects
• Mechanism of Action:
  • In skeletal muscle, MOTS-c inhibits the folate/purine pathway → increased endogenous AICAR → AMPK activation → improved glucose uptake and fat oxidation.
  • Under stress, MOTS-c translocates to the nucleus and interacts with stress-response programs (including NRF2-linked antioxidant genes), coordinating resilience.

Key Features & Benefits

• Supports insulin sensitivity and healthy glucose handling
• Boosts training capacity and muscular performance
• Encourages fat utilization and favorable body-composition support
• Promotes mitochondrial efficiency and cellular stress resilience
• Broad healthy-aging support via AMPK/NRF2 pathways

Who Benefits Most

• Athletes & highly active individuals seeking endurance, work capacity, and recovery
• Individuals focused on body recomposition and metabolic health
• Longevity enthusiasts optimizing cellular energy and stress defenses

Effects on Key Areas

• Blood sugar & insulin: Supports insulin sensitivity and uptake pathways
• Endurance & performance: Improves physical capacity in animal models; MOTS-c rises with human exercise
• Body composition: Promotes fat oxidation and healthier metabolic signaling
• Recovery & inflammation: Engages NRF2-driven antioxidant responses
• Cellular/mitochondrial function: Supports proteostasis and stress adaptation

Recommended Dosage & Administration

Typical market protocol: 2.5 mg once every 5 days by subcutaneous injection.

• Cycle length: 4–8 weeks is common in retail protocols
• Timing tips: Morning or pre-training on dose days; rotate SC sites (abdomen, outer thigh)
• Split dosing: Most protocols use a single SC dose on the scheduled day; advanced users sometimes split across the same day

Pen Calibration & Conversions (NordicP 10 mg pen example)

• 1 pen = 10 mg = 200 units
• 1 unit = 50 mcg
• 10 units = 0.5 mg;
• 20 units = 1 mg
• 50 units = 2.5 mg (one dose day)
• Each 10 mg pen provides about 4 full 2.5 mg doses, which lasts roughly 20 days when used every 5 days.

Actual needs vary by bodyweight, training load, age, and goals. Start conservatively and adjust within the protocol window.

What Is MOTS-c?

Discovered by researchers at the University of Southern California (Lee, Cohen, et al.), MOTS-c is a 16-amino-acid microprotein encoded by mitochondrial DNA. It acts as a mitokine—a mitochondria-to-nucleus signal that reprograms metabolism for performance and resilience. Landmark work in Cell Metabolism (2015) mapped its AMPK-centric mechanism; later studies showed nuclear translocation during stress and broad regulation of gene networks tied to antioxidant defense and recovery.

Benefits

• Higher training capacity and stamina
• Metabolic optimization—fuel partitioning and fat oxidation via AMPK
• Insulin-sensitivity support and healthier glycemic responses
• Inflammation and oxidative-stress moderation
• Mitochondrial efficiency and stress adaptation for healthy aging

Clinical Trials & Research

Cell Metabolism (2015) identified MOTS-c; showed improved insulin sensitivity, glucose uptake, and protection against diet-induced metabolic dysfunction in mice via folate → AICAR → AMPK signaling.

Cell Metabolism (2018) demonstrated nuclear translocation under metabolic stress and coordination of antioxidant/stress-response genes.

Nature Communications (2021): Exogenous MOTS-c enhanced physical capacity and healthspan markers in mice; in humans, circulating and intramuscular MOTS-c increase with acute exercise (exercise-induced). This was not a trial of injected MOTS-c in humans.

Additional human data find MOTS-c levels correlate with training status and change with structured exercise programs.

Reviews synthesize evidence that MOTS-c can reduce insulin resistance, improve muscle function, and modulate aging pathways, primarily from animal and cell studies, with growing human observational data.

Direct human trials showing improved cognition or sleep after MOTS-c administration have not been established. Some rodent and in-vitro work suggests neuroprotective effects or memory benefits using brain-targeted MOTS-c analogues, but translation to humans remains pending. Observational studies link lower circulating MOTS-c with conditions like obstructive sleep apnea, but that’s correlation—not proof that dosing MOTS-c improves sleep.

If you’ve seen statements that Nature Communications or Cell Metabolism showed human improvements in cognition, sleep, or athlete endurance from injected MOTS-c, those are misinterpretations. The endurance improvements were in mice, while human data primarily tracked exercise-induced changes in endogenous MOTS-c levels.

Applications in Sports & Fitness

• Endurance support: Preclinical data show higher running capacity and fatigue resistance; in athletes, training itself raises MOTS-c, suggesting synergy with hard blocks.
• Metabolic efficiency: AMPK activation favors carb/fat switching for longer efforts and “cleaner” energy.
• Recovery & resilience: Nuclear signaling and NRF2-pathways help manage oxidative stress after intense training.

Anti-doping note: Exogenous MOTS-c is prohibited for athletes under anti-doping rules; always check your sport’s regulations.

Possible Side Effects

Generally well-tolerated in preclinical models. User reports (and peptide-vendor guidance) note mild, transient effects when they occur:

• Headache
• Nausea or mild GI discomfort
• Temporary redness/irritation at the injection site

Avoid excessive dosing and follow sensible cycling. Comprehensive human safety data are still limited.

FAQs

What is MOTS-c?
A 16-aa mitochondria-encoded peptide that activates AMPK, improves metabolic signaling, and is induced by exercise.

Key benefits?
Metabolic efficiency, insulin-sensitivity support, endurance capacity (animals), cellular stress resilience, and healthy-aging pathways.

Who can use it?
Active individuals and body-recomposition/longevity seekers who want performance, recovery, and metabolic support—subject to personal health considerations and sport regulations.

Recommended dose & cycle?
A common retail protocol is 2.5 mg subcutaneous injection every 5 days, 4–8 weeks. 

How do I administer it?
Subcutaneous injection (abdomen or thigh); hold 10 seconds before withdrawing; rotate sites.

Is it legal for sport?
Exogenous MOTS-c is prohibited by anti-doping rules—check with your federation.

Why Nordic Peptides?
Consistent potency, clean formulation, and straightforward pen calibration for precise micro-dosing.

Conclusion

MOTS-c aligns metabolism with performance: stronger energy signaling, better fuel use, and stress-resilient recovery—plus healthy-aging pathways that help you feel (and perform) younger. Build more engine, last longer, bounce back faster.

Ready to accelerate recovery and maximize performance? Order Nordic Peptides MOTS-c today and experience elite-grade purity.